Bluefin Capital Management’s Merck MRK Stock Holding History

Bluefin Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$848	Buy	+56,500	New	+$6.71M	﹤0.01%	122
2024 Q1	–	Sell	-46,700	Closed	-$9.34K	–	240
2023 Q4	$9.34K	Buy	46,700 +36,700	+367%	+$3.81M	﹤0.01%	183
2023 Q3	$250	Buy	+10,000	New	+$1.08M	﹤0.01%	189
2022 Q1	–	Sell	-47,600	Closed	-$5K	–	862
2021 Q4	$5K	Buy	+47,600	New	+$3.79M	﹤0.01%	834
2019 Q4	–	Sell	-28,925	Closed	-$43K	–	685
2019 Q3	$43K	Buy	28,925 +17,816	+160%	+$1.43M	0.01%	385
2019 Q2	$7K	Sell	11,109 -3,563	-24%	-$273K	﹤0.01%	305
2019 Q1	$33K	Buy	+14,672	New	+$1.1M	﹤0.01%	305
2018 Q4	–	Sell	-41,710	Closed	-$41K	–	496
2018 Q3	$41K	Buy	+41,710	New	+$2.66M	﹤0.01%	404
2016 Q4	–	Sell	-4,611	Closed	-$13K	–	579
2016 Q3	$13K	Buy	+4,611	New	+$270K	﹤0.01%	391
2014 Q2	–	Sell	-2,201	Closed	-$500K	–	751
2014 Q1	$500K	Buy	+2,201	New	+$114K	0.03%	318

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bluefin Capital Management's MRK Position: Q2 2026 in Review

Bluefin Capital Management reduced its Merck (MRK) stake by 46% in Q2 2026, selling an estimated $216K and leaving 2,154 shares worth $277K. The position accounts for 0.07% of the portfolio, ranked #81.

Bluefin Capital Management first reported a position in MRK in Q2 2013 and has held it in 35 quarters since. The position peaked at $10.6M in Q4 2019. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Bluefin Capital Management held 2,154 shares of Merck worth $277K as of Q2 2026.
Bluefin Capital Management sold 1,846 Merck shares in Q2 2026, an estimated $216K.
Merck made up 0.07% of Bluefin Capital Management's portfolio in Q2 2026, its #81 holding.
Bluefin Capital Management first reported a position in Merck in Q2 2013 and has held it in 35 quarters since.
Bluefin Capital Management's Merck position peaked at $10.6M in Q4 2019.
3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bluefin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.